The mixed Q1 financial results for Exact Sciences suggest that the company did not meet all the expectations set by analysts or investors, which typically leads to a negative short-term reaction in the stock market. Given that financial performance, especially earnings reports, are critical indicators of a company's health, any deviation from expected results can significantly impact investor sentiment and stock price.